These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9448703)

  • 1. Molecular modelling and biological evaluation of a series of hydroxylated benzylideneanilines and benzylamines designed as tyrosine kinase inhibitors.
    Solomons KR; Lieberman HF; Groundwater PW; Hibbs DE; Hursthouse MB
    Anticancer Drug Des; 1997 Dec; 12(8):635-47. PubMed ID: 9448703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
    Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
    Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines.
    Bardelle C; Cross D; Davenport S; Kettle JG; Ko EJ; Leach AG; Mortlock A; Read J; Roberts NJ; Robins P; Williams EJ
    Bioorg Med Chem Lett; 2008 May; 18(9):2776-80. PubMed ID: 18434142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
    Kamath S; Buolamwini JK
    J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-tyrosine kinase activity of 3-(substituted-benzylidene)-1, 3-dihydro-indolin derivatives: investigation of their role against p60c-Src receptor tyrosine kinase with the application of receptor docking studies.
    Olgen S; Akaho E; Nebioglu D
    Farmaco; 2005; 60(6-7):497-506. PubMed ID: 15927182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The lead generation of protein tyrosine kinase inhibitors by quantitative structure-activity relationship analysis].
    Guo ZR; Goto S; Yang GZ; Terada H
    Yao Xue Xue Bao; 1992; 27(2):90-5. PubMed ID: 1414376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of the tyrosine kinase EphB4. Part 4: Discovery and optimization of a benzylic alcohol series.
    Barlaam B; Ducray R; Lambert-van der Brempt C; Plé P; Bardelle C; Brooks N; Coleman T; Cross D; Kettle JG; Read J
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2207-11. PubMed ID: 21441027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.
    Ducray R; Jones CD; Jung FH; Simpson I; Curwen J; Pass M
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4702-4. PubMed ID: 21764307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effects of some N-benzylideneanilines.
    Ozkay Y; Incesu Z; Işikdağ I; Yeşilkaya M
    Cell Biochem Funct; 2008; 26(1):102-6. PubMed ID: 17457959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer.
    Lippa B; Kauffman GS; Arcari J; Kwan T; Chen J; Hungerford W; Bhattacharya S; Zhao X; Williams C; Xiao J; Pustilnik L; Su C; Moyer JD; Ma L; Campbell M; Steyn S
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3081-6. PubMed ID: 17398092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
    Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
    J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of novel vascular endothelial growth factor receptor tyrosine kinases inhibitors: pharmacophore modeling, virtual screening and docking studies.
    Yu H; Wang Z; Zhang L; Zhang J; Huang Q
    Chem Biol Drug Des; 2007 Mar; 69(3):204-11. PubMed ID: 17441906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
    Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM
    Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors.
    Harris PA; Cheung M; Hunter RN; Brown ML; Veal JM; Nolte RT; Wang L; Liu W; Crosby RM; Johnson JH; Epperly AH; Kumar R; Luttrell DK; Stafford JA
    J Med Chem; 2005 Mar; 48(5):1610-9. PubMed ID: 15743202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase.
    Cumming JG; McKenzie CL; Bowden SG; Campbell D; Masters DJ; Breed J; Jewsbury PJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5389-94. PubMed ID: 15454232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of aniline headgroups for alkynyl thienopyrimidine dual EGFR/ErbB-2 kinase inhibitors.
    Waterson AG; Petrov KG; Hornberger KR; Hubbard RD; Sammond DM; Smith SC; Dickson HD; Caferro TR; Hinkle KW; Stevens KL; Dickerson SH; Rusnak DW; Spehar GM; Wood ER; Griffin RJ; Uehling DE
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1332-6. PubMed ID: 19208477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, growth and characterization of 4-bromo-4'chloro benzylidene aniline--a third order non linear optical material.
    Subashini A; Kumaravel R; Leela S; Evans HS; Sastikumar D; Ramamurthi K
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Mar; 78(3):935-41. PubMed ID: 21242098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation.
    Zidar N; Tomašić T; Šink R; Kovač A; Patin D; Blanot D; Contreras-Martel C; Dessen A; Premru MM; Zega A; Gobec S; Mašič LP; Kikelj D
    Eur J Med Chem; 2011 Nov; 46(11):5512-23. PubMed ID: 21963114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.